Company F-star Therapeutics, Inc.
Equities
FSTX
US30315R1077
Biotechnology & Medical Research
Business Summary
Number of employees: 84
Managers
Managers | Title | Age | Since |
---|---|---|---|
Neil Brewis
CEO | Chief Executive Officer | 57 | 19/11/20 |
Lindsey Trickett
IRC | Investor Relations Contact | - | - |
Trish Hurley
LAW | General Counsel | - | - |
James Sandy
PRN | Corporate Officer/Principal | - | 28/02/22 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Neil Brewis
CEO | Chief Executive Officer | 57 | 19/11/20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 21,981,919 | 21,095,716 ( 95.97 %) | 0 | 95.97 % |
Company contact information
F-star Therapeutics, Inc.
Eddeva B920 Babraham Research Campus
CB22 3AT, Cambridge
+
http://www.f-star.comSector
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |